These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 10859320)

  • 1. Actin-latrunculin A structure and function. Differential modulation of actin-binding protein function by latrunculin A.
    Yarmola EG; Somasundaram T; Boring TA; Spector I; Bubb MR
    J Biol Chem; 2000 Sep; 275(36):28120-7. PubMed ID: 10859320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An unexplained sequestration of latrunculin A is required in neutrophils for inhibition of actin polymerization.
    Pring M; Cassimeris L; Zigmond SH
    Cell Motil Cytoskeleton; 2002 Jun; 52(2):122-30. PubMed ID: 12112154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latrunculin alters the actin-monomer subunit interface to prevent polymerization.
    Morton WM; Ayscough KR; McLaughlin PJ
    Nat Cell Biol; 2000 Jun; 2(6):376-8. PubMed ID: 10854330
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of actin polymerization by latrunculin A.
    Coué M; Brenner SL; Spector I; Korn ED
    FEBS Lett; 1987 Mar; 213(2):316-8. PubMed ID: 3556584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of latrunculin-A, an actin monomer-binding drug.
    Ayscough K
    Methods Enzymol; 1998; 298():18-25. PubMed ID: 9751867
    [No Abstract]   [Full Text] [Related]  

  • 6. Decreased actin solubility observed during ATP-depletion is mimicked by severing agents but not depolymerizing agents in isolated and cultured proximal tubular cells.
    White P; Gu L; Chen J
    Clin Physiol Funct Imaging; 2002 Sep; 22(5):312-9. PubMed ID: 12487003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The actin cytoskeleton is required for receptor-mediated endocytosis in mammalian cells.
    Lamaze C; Fujimoto LM; Yin HL; Schmid SL
    J Biol Chem; 1997 Aug; 272(33):20332-5. PubMed ID: 9252336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latrunculin A is a potent inducer of aggregation of polymorphonuclear leukocytes.
    Oliveira CA; Chedraoui S; Mantovani B
    Life Sci; 1997; 61(6):603-9. PubMed ID: 9250716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latrunculin B or ATP depletion induces cofilin-dependent translocation of actin into nuclei of mast cells.
    Pendleton A; Pope B; Weeds A; Koffer A
    J Biol Chem; 2003 Apr; 278(16):14394-400. PubMed ID: 12566455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of latrunculin reveal requirements for the actin cytoskeleton during secretion from mast cells.
    Pendleton A; Koffer A
    Cell Motil Cytoskeleton; 2001 Jan; 48(1):37-51. PubMed ID: 11124709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of actin dynamics by proteins made of beta-thymosin repeats: the actobindin family.
    Hertzog M; Yarmola EG; Didry D; Bubb MR; Carlier MF
    J Biol Chem; 2002 Apr; 277(17):14786-92. PubMed ID: 11856744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An antiprion effect of the anticytoskeletal drug latrunculin A in yeast.
    Bailleul-Winslett PA; Newnam GP; Wegrzyn RD; Chernoff YO
    Gene Expr; 2000; 9(3):145-56. PubMed ID: 11243411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of actin filaments and integrins in the binding step in collagen phagocytosis by human fibroblasts.
    Segal G; Lee W; Arora PD; McKee M; Downey G; McCulloch CA
    J Cell Sci; 2001 Jan; 114(Pt 1):119-129. PubMed ID: 11112696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of interdomain motion in g-actin by the natural product latrunculin: a molecular dynamics study.
    Rennebaum S; Caflisch A
    Proteins; 2012 Aug; 80(8):1998-2008. PubMed ID: 22488806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of latrunculin-A resistance in HeLa cells by expression of R183A D184A mutant beta-actin.
    Fujita M; Ichinose S; Kiyono T; Tsurumi T; Omori A
    Oncogene; 2003 Jan; 22(4):627-31. PubMed ID: 12555075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latrunculin with a highly oxidized thiazolidinone ring: structure assignment and actin docking.
    Ahmed SA; Odde S; Daga PR; Bowling JJ; Mesbah MK; Youssef DT; Khalifa SI; Doerksen RJ; Hamann MT
    Org Lett; 2007 Nov; 9(23):4773-6. PubMed ID: 17929935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of latrunculin A on immunological phagocytosis and macrophage spreading-associated changes in the F-actin/G-actin content of the cells.
    Oliveira CA; Kashman Y; Mantovani B
    Chem Biol Interact; 1996 Mar; 100(2):141-53. PubMed ID: 8646787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semisynthetic latrunculin B analogs: studies of actin docking support a proposed mechanism for latrunculin bioactivity.
    Kudrimoti S; Ahmed SA; Daga PR; Wahba AE; Khalifa SI; Doerksen RJ; Hamann MT
    Bioorg Med Chem; 2009 Nov; 17(21):7517-22. PubMed ID: 19800245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The control of actin nucleotide exchange by thymosin beta 4 and profilin. A potential regulatory mechanism for actin polymerization in cells.
    Goldschmidt-Clermont PJ; Furman MI; Wachsstock D; Safer D; Nachmias VT; Pollard TD
    Mol Biol Cell; 1992 Sep; 3(9):1015-24. PubMed ID: 1330091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of latrunculin-B on outflow facility in monkeys.
    Peterson JA; Tian B; Geiger B; Kaufman PL
    Exp Eye Res; 2000 Mar; 70(3):307-13. PubMed ID: 10712817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.